The Number 1 Forum for Life Science IP and Regulatory Professionals
This industry premier life science legal event will gather the leading pharmaceutical and biotech professionals for 3 days of practical discussion on the protection of pharmaceutical drugs based on patent and regulatory exclusivities.
Attend this face-to-face industry summit and have candid discussions with the European life science intellectual property and regulatory experts. The event allows you to form commercially important business relationships, whilst forming a life science legal strategy for 2024 and beyond.
Once again, this year’s summit will host the pre-event SPC & PTE Forum 2024, allowing a mixed audience of in-house counsels, private practice members and key regulators to discuss the strategies and updates concerning SPCs and PTEs. Add this to your registration and form a comprehensive exclusivity strategy for 2024.
DOWNLOAD THE 2024 EVENT AGENDA TODAY
Highlights for 2024 Include
- A review of the latest decisions regarding the SPC waiver and its impact upon your generic and innovator life science exclusivity strategy.
- Discover the intersection between regulatory and IP law with industry-led sessions on: clinical trials, data exclusivity, a Tecfidera case law review and the Pharmaceutical Strategy for Europe.
- Understand the requirements for patentability within the life sciences industry with panel sessions on patent quality, G2/21, enablement and the PTAB.
- Discuss the ways in which the UPC is impacting your life science strategy with an industry-led session and judges panel.
Which In-House Companies Are Attending This October?
Job Titles Include: Assistant Director, Patent Litigation, Associate General Patent Counsel, Deputy General Counsel, Global Head of Intellectual Property Litigation, Director - Group Patents Legal IP, Director- Dispute Resolution, Director IP, Dutch and European Patent Attorney, European Patent Attorney Director, Intellectual Property, Expert Patent Attorney, General Counsel, Board Member, General Manager – Global Intellectual Property, Global Head of IP, Global Head of IP Litigation, Group Head-IP, Head of HP Patent Strategies, Head of IP, Head of IP & European Patent Attorney, Head of Legal, Head of Patent Examination, Head of Patent Section, Head of Patents- Pharma and Consumer Health, Head Patent Department, Head Patent Litigation, Head, IP – Europe, Intellectual Property Director, IP & Information Specialist, IP Counsel, IP Expert, European Patent Attorney, IP Manager, Lead IP Litigation Counsel, EMENA, Lead Patent Counsel, Manager & Head of Patents, Patent Attorney, Patent Counsel Lead Development & Patent Portfolio, Patent Examiner, Patent Law Director, Patent Manager, Principal Patent Attorney, Senior Counsel, Senior Counsel – Patent Litigation, Senior Counsel European IP and Regulatory Litigation, Senior Counsel- Intellectual Property & Litigation Law, Senior Counsel, Digital and Device Intellectual Property, Senior Director Intellectual Property, Senior IP Counsel - European Patent Attorney, Senior IP Counsel, Litigation, Senior Legal Counsel, Senior Litigation Counsel, Senior Patent Attorney, Senior Patent Counsel, Senior Patent Manager Patent Litigation, Sr. Director Legal, IP & Product Portfolio, SVP IP, Vice President and Head of Legal & Intellectual Property, Vice President IP